Genenta Science S.p.A. Unsponsored ADR (NASDAQ:GNTA - Get Free Report) shares fell 1.3% during mid-day trading on Thursday . The company traded as low as $3.84 and last traded at $3.90. 3,226 shares traded hands during mid-day trading, a decline of 81% from the average session volume of 16,827 shares. The stock had previously closed at $3.95.
Genenta Science Stock Up 1.5%
The business's fifty day simple moving average is $3.97 and its two-hundred day simple moving average is $4.02.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in GNTA. Allianz SE bought a new stake in shares of Genenta Science in the 4th quarter worth approximately $444,000. Citadel Advisors LLC bought a new position in Genenta Science in the fourth quarter worth $46,000. Finally, Algebris UK Ltd lifted its position in Genenta Science by 122.2% in the first quarter. Algebris UK Ltd now owns 100,000 shares of the company's stock worth $368,000 after purchasing an additional 55,000 shares during the period. Institutional investors own 15.13% of the company's stock.
About Genenta Science
(
Get Free Report)
Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter.
Further Reading
Before you consider Genenta Science, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genenta Science wasn't on the list.
While Genenta Science currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
